Upon screening of several genes involved in drug resistance and cell survival of MCL, we found the striking upregulation of BCL2L1 (encodes Bcl-xL) and downregulation of BAX in highly BTZ-resistant cells (Figure 3). The gene discussed is CASC3; the disease is mantle cell lymphoma.